30
IGRT in Lung Cancer Dr Santam Chakraborty Assistant Professor Radiation Oncology

IGRT in lung cancer

Embed Size (px)

Citation preview

Page 1: IGRT in lung cancer

IGRT in Lung

CancerDr Santam Chakraborty

Assistant Professor

Radiation Oncology

Page 2: IGRT in lung cancer

IGRT

Image Guided Radiotherapy

Describes a chain rather than a single process

“Exclusive” of the delivery process

Typically “onboard” guidance utilized

Leads to action that improves / verifies accuracy

Page 3: IGRT in lung cancer

T. Gupta, C. A. Narayan, Image-guided radiation therapy: Physician’s perspectives. J. Med. Phys. 37, 174–

182 (2012).

Page 4: IGRT in lung cancer

Why IGRT

S. S. Korreman, Image-guided radiotherapy and motion management in lung cancer. Br. J. Radiol. 88,

20150100 (2015).

Page 5: IGRT in lung cancer

Why IGRT ...

J.-J. Sonke, J. Lebesque, M. van Herk, Variability of four-dimensional computed tomography patient models. Int. J. Radiat. Oncol.

Biol. Phys. 70, 590–598 (2008).

Page 6: IGRT in lung cancer

Target Volume Changes due to Imaging

S. S. Korreman, Image-guided radiotherapy and motion management in lung cancer. Br. J. Radiol. 88,

20150100 (2015).

Page 7: IGRT in lung cancer

FDG PET CT in Target Volume Delineation

Y. Zheng et al., FDG-PET/CT imaging for tumor staging

and definition of tumor volumes in radiation treatment

planning in non-small cell lung cancer. Oncol. Lett. 7,

1015–1020 (2014).

● 35% have change in stage

assignment

● Fused CT / PET result in target

volume changes in 60%

● Reduced variability seen in

GTV delineation between

observers.

Page 8: IGRT in lung cancer

IGRT Technology & Imaging

Image Guided RT

Ionizing Radiation Based Other Technologies

Planar Imaging Volumetric Imaging

KV Fluoro / X ray

MV Fluoro / X ray

KV CT

MV CT

Electromagnetic Tracking

Optical Surface Tracking

Ultrasound Tracking

MRI based Tracking

Page 9: IGRT in lung cancer

IGRT Image Technologies

Technology Energy Type Accuracy Comments

EPID MV 2D 1-2 mm Surrogate imaging of soft tissue

KV Xray KV 2D 1-2 mm Better resolution w.r.t. EPID

CBCT KV 3D < 1mm Volumetric “slow” scan.

MVCT MV 3D < 1mm Can be useful for adaptive radiotherapy

Stereoscopic Xray KV 2D < 1mm Useful in tumor tracking. Oblique angles.

USG - 3D 3 mm Main utility in prostate cancers

Surface - 2D 1 mm Surface based optical tracking and localization

Transponders - 2D - Independent system for tumor tracking

Page 10: IGRT in lung cancer

IGRT Issues in Lung Cancer

1. Lung tumors are difficult to see with megavoltage imaging.

1. Significant movement of the tumor in all 3 directions in addition to “hysteresis”

1. Significant changes in the course of treatment

1. Lung motion is independent of bony motion

Page 11: IGRT in lung cancer

Difficulty in

Visualization

Page 12: IGRT in lung cancer

EPID based matching

Page 13: IGRT in lung cancer

Difficulty in

Visualization

Page 14: IGRT in lung cancer

Changes in

Volume

K. R. Britton et al., Assessment of Gross Tumor Volume Regression and Motion Changes

During Radiotherapy for Non–Small-Cell Lung Cancer as Measured by Four-

Dimensional Computed Tomography. International Journal of Radiation

Oncology*Biology*Physics. 68, 1036–1046 (2007).

Page 15: IGRT in lung cancer

Changes in

Volume

L. A. Dawson, M. B. Sharpe, Image-guided radiotherapy: rationale, benefits, and limitations.

Lancet Oncol. 7, 848–858 (2006).

Page 16: IGRT in lung cancer

Changes in

Volume

Page 17: IGRT in lung cancer

Ways to implement IGRT

IGRT Protocols

Offline Online

Q : Which one can correct for random errors?

➢ Large step

reduction

➢ Limited workload

➢ Mean error

correction

➢ Allows larger dose

through smaller

margins

➢ Daily error

correction

Page 18: IGRT in lung cancer

Basic points prior to Imaging

1. Reproducible comfortable positioning with immobilization

2. Tattoos help but skin marks mobile over bone (~ 5 mm)

3. Laser alignment is must

4. Rigid couchtop with indexed immobilization

5. Assume setup is incorrect unless proven otherwise

Page 19: IGRT in lung cancer

Bone Matching vs Soft Tissue Matching

M. Guckenberger, Image-guided Radiotherapy Based on Kilovoltage Cone-beam Computed Tomography — A Review of Technology and

Clinical Outcome. European Oncology & Haematology. 07, 121 (2011).

Page 20: IGRT in lung cancer

Good CBCT Match

Slide Image

courtesy Dr J P

Aggarwal

(TMH)

Page 21: IGRT in lung cancer

What to match on CBCT

Page 22: IGRT in lung cancer

4D-CBCT

https://www.aapm.org/meetings

/06ss/documents/SonkeConeBe

am.pdf

Page 23: IGRT in lung cancer

Systematic vs Random Error

Systematic error : Reproducible, consistent errors, occurring in the same

direction and of similar magnitude.

It affects the dose distribution by producing a “miss”

Defined as the AVERAGE of a set of displacement.

Random error: Varies in direction and magnitude in each fraction.

It affects the dose distribution by producing a “blur”

Defined as the STANDARD DEVIATION of a set of displacements

Page 24: IGRT in lung cancer

Example Systematic & Random Error

https://docs.google.com/spreadsheets/d/1_w1dJzakVPJeMqFFRr5PZs4MVmKrN4lFPIMr0tRHZWA/edit?usp=sharing

Page 25: IGRT in lung cancer

NAL correction

workflow

Page 26: IGRT in lung cancer

Example of a NAL protocol

Page 27: IGRT in lung cancer

Levels of IGRT implementation

0 1 2

RT Planning

Done more

accurately

(e.g. contrast /

PET CT /

4DCT)

3 4

Surrogate

based

matching

using bony

anatomy

Matching

based on

target

anatomy

(implanted

markers /

volumetric)

Adjustment /

correction for

intrafraction

motion

Adaptive

Radiotherapy

National Cancer Action Team, “National Radiotherapy Implementation Group Report IGRT Final Guidance for Implementation and Use”

(NHS, 2012), (available at link).

Page 28: IGRT in lung cancer

IGRT Lung Recommendation

Level 0 CT with contrast

PET CT for accurate target delineation

4DCT for accurate capture of motion

For all patients

Level 1 Planar imaging with matching to reliable bony surrogate

± volumetric imaging weekly (tumor morphology / volume changes)*

Pancoast tumors

3DCRT

Level 2 Imaging with offline matching and NAL pathway with target volume

matching (volumetric / fiducial)

± volumetric imaging weekly (tumor morphology / volume changes)*

All other lung tumors

3DCRT

Level 2 Imaging with daily online correction with target volume matching

(volumetric / fiducial)

Complex IMRT /

Boost or reduced

margins

Level 3 Intrafraction motion monitoring SABR

National Cancer Action Team, “National Radiotherapy Implementation Group Report IGRT Final Guidance for Implementation and Use”

(NHS, 2012), (available at link).

Page 29: IGRT in lung cancer

Imaging Dose & consequences

Modality Effective Dose (mSv) Daily IGRT (30#)

Diagnostic Chest CT 6.4 -

EPID AP 3.6 246

EPID Lat 4.6

KV CBCT 24.6 738

KV XVI (Elekta) 8.1 243

Estimated life-time probability of 2nd malignancy : 1.2% - 3.7%

M. J. Murphy et al., The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task

Group 75. Med. Phys. 34, 4041–4063 (2007).

Page 30: IGRT in lung cancer

Conclusions

● Image guided radiotherapy is an integral part of any conformal radiotherapy

program for lung cancer

● IGRT allows safer radiotherapy in terms of OAR dose reduction.

● IGRT however needs specialized equipment and expertise

● A team effort is needed for commissioning and implementation

● Physics and Technologists need to be a part of the team !!